Data Supplement from Preclinical Evaluation of Multistep Targeting of Diasialoganglioside GD2 Using an IgG-scFv Bispecific Antibody with High Affinity for GD2 and DOTA Metal Complex

Supplementary Figure S1. Modeling comparison of two different therapy regimens. Supplementary Figure S2. Positron-emission tomography imaging data for I-124 labeled bispecific antibody in tumor-bearing mice. Supplementary Figure S3. Biodistribution data I-124 labeled bispecific antibody in tumor-bearing mice. Supplementary Tables 1 and 2 are biodistribution data following various pretargeting experiments with the bispecific antibody. Supplementary Table 3 contains hematological and clinical chemistry data from treatment study.